ArticlePharmaceuticals (Basel, Switzerland)2022

Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers.

Ratnakar Reddy Kuchukulla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.